All 0 3 0 3 O
participants 4 16 4 16 O
under 17 22 17 22 O
the 23 26 23 26 O
care 27 31 27 31 O
of 32 34 32 34 O
St. 35 38 35 38 O
Jude 39 43 39 43 O
physicians 44 54 44 54 O
with 55 59 55 59 O
known 60 65 60 65 O
or 66 68 66 68 O
suspected 69 78 69 78 O
neoplastic 79 89 79 89 B-chronic_disease
disease 90 97 90 97 I-chronic_disease

Female 0 6 98 104 B-gender
participants 7 19 105 117 I-gender
of 20 22 118 120 O
childbearing 23 35 121 133 O
age 36 39 134 137 B-age
must 40 44 138 142 O
not 45 48 143 146 O
be 49 51 147 149 O
lactating 52 61 150 159 O
due 62 65 160 163 O
to 66 68 164 166 O
theoretical 69 80 167 178 O
potential 81 90 179 188 O
harm 91 95 189 193 O
to 96 98 194 196 O
the 99 102 197 200 O
infant 103 109 201 207 O
from 110 114 208 212 O
exposure 115 123 213 221 O
to 124 126 222 224 O
radiation 127 136 225 234 O

More 0 4 235 239 O
than 5 9 240 244 O
6 10 11 245 246 B-lower_bound
MET 12 15 247 250 O
PET 16 19 251 254 B-treatment
scans 20 25 255 260 I-treatment
within 26 32 261 267 O
the 33 36 268 271 O
previous 37 45 272 280 B-upper_bound
12 46 48 281 283 I-upper_bound
months 49 55 284 290 I-upper_bound

No 0 2 291 293 O
limit 3 8 294 299 O
on 9 11 300 302 O
age 12 15 303 306 B-age
or 16 18 307 309 O
gender 19 25 310 316 O

Participants 0 12 317 329 O
will 13 17 330 334 O
have 18 22 335 339 O
had 23 26 340 343 O
, 26 27 343 344 O
or 28 30 345 347 O
are 31 34 348 351 O
scheduled 35 44 352 361 O
to 45 47 362 364 O
have 48 52 365 369 O
clinical 53 61 370 378 O
imaging 62 69 379 386 O
evaluations 70 81 387 398 O
which 82 87 399 404 O
may 88 91 405 408 O
include 92 99 409 416 O
FDG 100 103 417 420 B-treatment
PET 104 107 421 424 B-treatment
CT 108 110 425 427 B-treatment
, 110 111 427 428 O
or 112 114 429 431 O
CT 115 117 432 434 O
, 117 118 434 435 O
or 119 121 436 438 O
MRI 122 125 439 442 B-treatment
within 126 132 443 449 O
4 133 134 450 451 B-upper_bound
weeks 135 140 452 457 I-upper_bound
of 141 143 458 460 O
entry 144 149 461 466 O

